VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
21 hedge funds and large institutions have $114M invested in VectivBio Holding AG Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
16% less funds holding
Funds holding: 25 → 21 (-4)
51% less capital invested
Capital invested by funds: $233M → $114M (-$119M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$495K |
| 2 |
CA
CHI Advisors
New York
|
+$408K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$355K |
| 4 |
JG
Jefferies Group
New York
|
+$82K |
| 5 |
PCM
Pinz Capital Management
New York
|
+$59.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$51.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.21M |
| 3 |
Millennium Management
New York
|
-$335K |
| 4 |
Squarepoint
New York
|
-$193K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$174K |
VECT Hedge Fund Activity: Q4 2021 in Review
21 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q4 2021, worth a combined $114M — down 51% from $233M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VECT and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was OrbiMed, adding an estimated $495K. The largest seller was NEA Management Company, exiting entirely with an estimated $51.8M sold.
- 21 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q4 2021, down from 25 in Q3 2021.
- Funds reported $114M of VectivBio Holding AG Ordinary Shares stock for Q4 2021, down 51% quarter-over-quarter.
- 3 funds opened new VectivBio Holding AG Ordinary Shares positions in Q4 2021 and 7 closed out, a net change of -4 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q4 2021 was OrbiMed, an estimated $495K added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q4 2021 was NEA Management Company, an estimated $51.8M sold.
Based on aggregated 13F filings for Q4 2021.